AI assistant
Sending…
LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2021
Mar 19, 2021
33431_dirs_2021-03-19_88465041-42df-4fc9-a9de-6ca523c42c01.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2021-03-12
Reporting Person: Kimball Dawn (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-12 | Common Stock | A | 5000 | $12.09 | Acquired | 5000 | Direct |
| 2021-03-12 | Common Stock | A | 13608 | $12.09 | Acquired | 18608 | Direct |
| 2021-03-12 | Common Stock | D | 2476 | $12.09 | Disposed | 16132 | Direct |
| 2021-03-12 | Common Stock | D | 6453 | $12.09 | Disposed | 9679 | Direct |
More from LIFECORE BIOMEDICAL, INC. \DE\
Regulatory Filings
2026
Jun 5
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Jan 16
Investor Presentation
2025
Nov 17
Interim / Quarterly Report
2025
Nov 6
Earnings Release
2025
Nov 6
Declaration of Voting Results & Voting Rights Announcements
2025
Oct 31
Major Shareholding Notification
2025
Oct 17